Improving Obsessive-compulsive Disorder Treatments: from Lesions to Neuromodulation Targets

Recruiting N/A Interventional Study
Obsessive-Compulsive Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 75
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
32 (estimated)
Sponsor
Fundacao Champalimaud · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
While in most cases of obsessive-compulsive disorder (OCD) a cause cannot be identified, this syndrome may develop as a consequence of focal brain lesions. Neuropsychiatric disorders secondary to brain insults are open windows to understand their underlying neurobiology. Different neuroimaging analysis methods, including pooled lesion topography and lesion network mapping, can be used to study les…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age between 18 and 75 years; * Established diagnosis of Obsessive-Compulsive Disorder according to Diagnostic and statistical manual of mental disorders 5 (DSM5) criteria; * Capacity to give consent; * Fluent in Portuguese and/or English; * If potential for pregnancy, agrees t…
Contacts

Sofia Marques

(+351) 210 480 048

sofia.marques@research.fchampalimaud.org

CONTACT

Gonçalo Cotovio, MD, PhD

(+351) 210 480 048

goncalo.cotovio@neuro.fchampalimaud.org

CONTACT